CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 224 enrolled
Drug / intervention
Dexketoprofen +1 moredrug
Likely dose
Dexketoprofen 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02159547
NCT02159547Phase 4Completed
CompareCT.gov

Study of Comparing Dexketoprofen to Placebo in Migraine Attack

Akdeniz University·interventional·Posted Jun 10, 2014·Updated Jul 23, 2015

In Brief

A Phase 4 clinical trial evaluating Dexketoprofen and Normal Saline for Migraine. Completed, enrolled 224 participants across 1 site.

Detailed Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 10, 2014
Enrollment StartMay 1, 2014
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 12.1 years ago

Interventions

Dexketoprofendrug

50 mg intravenous arveles in 50 ml saline in 5 minutes

Normal Salineother

50 ml normal saline